Concurrent carboplatin and paclitaxel with pelvic radiation therapy in the primary treatment of cervical cancer - Discussion

被引:0
|
作者
Burke, James J., II [1 ]
机构
[1] Carolinas Med Ctr, Charlotte, NC 28203 USA
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer
    Choy, H
    Akerley, W
    Safran, H
    Graziano, S
    Chung, C
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 117 - 119
  • [32] Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer
    Agarwala, S. S.
    Cano, E.
    Heron, D. E.
    Johnson, J.
    Myers, E.
    Sandulache, V.
    Bahri, S.
    Ferris, R.
    Wang, Y.
    Argiris, A.
    ANNALS OF ONCOLOGY, 2007, 18 (07) : 1224 - 1229
  • [33] Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer
    Yavas, Guler
    Yavas, Cagdas
    Sen, Erdem
    Oner, Irem
    Celik, Cetin
    Ata, Ozlem
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (01) : 42 - 47
  • [34] Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    McClurkan, S
    Gray, JR
    Stroup, SL
    Burris, HA
    Yardley, DA
    Bradof, JE
    Yost, K
    Ellis, JK
    Greco, FA
    CANCER JOURNAL, 2002, 8 (04): : 311 - 321
  • [35] Induction carboplatin/paclitaxel/gemcitabine (CPG) followed by concurrent weekly carboplatin/paclitaxel (CP) and radiation therapy in unresectable stage III non small cell lung cancer (NSCLC).
    Oniga, F
    Paccagnella, A
    Fasan, S
    Ardit, S
    Gatti, C
    Biason, R
    Medici, M
    D'Amanzo, P
    Ghi, MG
    Nascimben, O
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 703S - 703S
  • [36] CISPLATIN/PACLITAXEL VS CARBOPLATIN/PACLITAXEL TREATMENT IN ADVANCED CERVICAL CANCER: POOLED ANALYSIS DATA
    Lorusso, D.
    Petrelli, F.
    Coinu, A.
    Cabiddu, M.
    Ghilardi, M.
    Borgonovo, K.
    Cremonesi, M.
    Raspagliesi, F.
    Barni, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [37] Preliminary analysis of paclitaxel, carboplatin and concurrent radiation in the treatment of patients with advanced non-small cell lung cancer
    Choy, H
    Akerley, W
    Safran, H
    Graziano, S
    Chung, C
    SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (02) : S15 - S18
  • [38] A Phase I Study of Concurrent Weekly Carboplatin and Paclitaxel Combined With Intensity-Modulated Pelvic Radiotherapy as an Adjuvant Treatment for Early-Stage Cervical Cancer Patients With Positive Pelvic Lymph Nodes
    Mabuchi, Seiji
    Takahashi, Ryoko
    Isohashi, Fumiaki
    Yokoi, Takeshi
    Ito, Kimihiko
    Tsutui, Tateki
    Ogata, Toshiyuki
    Yoshioka, Yasuo
    Ogawa, Kazuhiko
    Kimura, Tadashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (07) : 1279 - 1286
  • [39] Combination therapy with radiation and weekly paclitaxel/carboplatin as definitive treatment for locally advanced esophageal cancer.
    Doherty, Mark
    Cowzer, Darren
    Kelly, Ciara Marie
    Battley, Jodie Emma
    Leonard, Gregory D.
    Power, Derek Gerard
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Paclitaxel, Carboplatin, and Bevacizumab in Advanced Cervical Cancer: A Treatment Response and Safety Analysis
    Tao, Wanjun
    Yang, Jia
    Jiang, Yongxian
    Chen, Wenwen
    Wang, Yixin
    DOSE-RESPONSE, 2020, 18 (03):